UniProt P32507
Nectin-2 (P32507)
Nectin-2 (UniProt P32507): 6 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P32507
- Protein
- Nectin-2
- Experimental structures
- 6
- Predicted models
- 1
Structures
7 records of P32507 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4FMK | Crystal structure of mouse nectin-2 extracellular fragment D1-D2 | x-ray diffraction | A | — | — |
| 4FMK | Crystal structure of mouse nectin-2 extracellular fragment D1-D2 | x-ray diffraction | A | — | — |
| 4FN0 | Crystal structure of mouse nectin-2 extracellular fragment D1-D2, 2nd crystal form | x-ray diffraction | A, B, C | — | — |
| 4FN0 | Crystal structure of mouse nectin-2 extracellular fragment D1-D2, 2ND crystal form | x-ray diffraction | A, B, C | — | — |
| 4FS0 | Crystal structure of mutant F136D of mouse nectin-2 extracellular fragment D1-D2 | x-ray diffraction | A | — | — |
| 4FS0 | Crystal structure of mutant F136D of mouse nectin-2 extracellular fragment D1-D2 | x-ray diffraction | A | — | — |
| P32507 | AlphaFold monomer V2.0 prediction for nectin-2 (P32507) | predicted | A | — | — |
Experiment against prediction
- 4FN0 chain A against the predicted model P32507: TM-score 0.96, RMSD 1.49 Å
- 4FN0 chain A against the predicted model P32507: TM-score 0.96, RMSD 1.49 Å
- 4FN0 chain C against the predicted model P32507: TM-score 0.95, RMSD 1.49 Å
- 4FN0 chain C against the predicted model P32507: TM-score 0.95, RMSD 1.49 Å
- 4FMK chain A against the predicted model P32507: TM-score 0.94, RMSD 1.80 Å
- 4FMK chain A against the predicted model P32507: TM-score 0.94, RMSD 1.80 Å
- 4FS0 chain A against the predicted model P32507: TM-score 0.91, RMSD 1.83 Å
- 4FS0 chain A against the predicted model P32507: TM-score 0.91, RMSD 1.83 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.